Literature DB >> 28600462

Failure of alemtuzumab therapy to control MOG encephalomyelitis.

Brigitte Wildemann1, Sven Jarius2, Alexander Schwarz2, Ricarda Diem2, Andrea Viehöver2, Stefan Hähnel2, Markus Reindl2, Mirjam Korporal-Kuhnke2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28600462     DOI： 10.1212/WNL.0000000000004087

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  12 in total

Review 1.  [Aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis. A brief review].

Authors:  Sven Jarius; Brigitte Wildemann
Journal:  Nervenarzt       Date:  2021-03-31       Impact factor: 1.214

2.  Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Authors:  Yael Hacohen; Yu Yi Wong; Christian Lechner; Maciej Jurynczyk; Sukhvir Wright; Bahadir Konuskan; Judith Kalser; Anne Lise Poulat; Helene Maurey; Esther Ganelin-Cohen; Evangeline Wassmer; Chery Hemingway; Rob Forsyth; Eva Maria Hennes; M Isabel Leite; Olga Ciccarelli; Banu Anlar; Rogier Hintzen; Romain Marignier; Jacqueline Palace; Matthias Baumann; Kevin Rostásy; Rinze Neuteboom; Kumaran Deiva; Ming Lim
Journal:  JAMA Neurol       Date:  2018-04-01       Impact factor: 18.302

Review 3.  [MOG encephalomyelitis: international recommendations on diagnosis and antibody testing].

Authors:  S Jarius; F Paul; O Aktas; N Asgari; R C Dale; J de Seze; D Franciotta; K Fujihara; A Jacob; H J Kim; I Kleiter; T Kümpfel; M Levy; J Palace; K Ruprecht; A Saiz; C Trebst; B G Weinshenker; B Wildemann
Journal:  Nervenarzt       Date:  2018-12       Impact factor: 1.214

4.  Treatment of MOG antibody associated disorders: results of an international survey.

Authors:  D H Whittam; V Karthikeayan; E Gibbons; R Kneen; S Chandratre; O Ciccarelli; Y Hacohen; J de Seze; K Deiva; R Q Hintzen; B Wildemann; S Jarius; I Kleiter; K Rostasy; P Huppke; B Hemmer; F Paul; O Aktas; A K Pröbstel; G Arrambide; M Tintore; M P Amato; M Nosadini; M M Mancardi; M Capobianco; Z Illes; A Siva; A Altintas; G Akman-Demir; L Pandit; M Apiwattankul; J Y Hor; S Viswanathan; W Qiu; H J Kim; I Nakashima; K Fujihara; S Ramanathan; R C Dale; M Boggild; S Broadley; M A Lana-Peixoto; D K Sato; S Tenembaum; P Cabre; D M Wingerchuk; B G Weinshenker; B Greenberg; M Matiello; E C Klawiter; J L Bennett; A I Wallach; I Kister; B L Banwell; A Traboulsee; D Pohl; J Palace; M I Leite; M Levy; R Marignier; T Solomon; M Lim; S Huda; A Jacob
Journal:  J Neurol       Date:  2020-07-04       Impact factor: 4.849

Review 5.  Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?

Authors:  Franziska Di Pauli; Thomas Berger
Journal:  Front Immunol       Date:  2018-11-29       Impact factor: 7.561

Review 6.  Update on pediatric optic neuritis.

Authors:  Jane H Lock; Nancy J Newman; Valérie Biousse; Jason H Peragallo
Journal:  Curr Opin Ophthalmol       Date:  2019-11       Impact factor: 3.761

7.  Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.

Authors:  S Jarius; C Würthwein; J R Behrens; J Wanner; J Haas; F Paul; B Wildemann
Journal:  J Neuroinflammation       Date:  2018-01-18       Impact factor: 8.322

8.  Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.

Authors:  S Jarius; F B König; I Metz; K Ruprecht; F Paul; W Brück; B Wildemann
Journal:  J Neuroinflammation       Date:  2017-08-29       Impact factor: 8.322

Review 9.  MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.

Authors:  S Jarius; K Ruprecht; J P Stellmann; A Huss; I Ayzenberg; A Willing; C Trebst; M Pawlitzki; A Abdelhak; T Grüter; F Leypoldt; J Haas; I Kleiter; H Tumani; K Fechner; M Reindl; F Paul; B Wildemann
Journal:  J Neuroinflammation       Date:  2018-03-19       Impact factor: 8.322

Review 10.  MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.

Authors:  S Jarius; F Paul; O Aktas; N Asgari; R C Dale; J de Seze; D Franciotta; K Fujihara; A Jacob; H J Kim; I Kleiter; T Kümpfel; M Levy; J Palace; K Ruprecht; A Saiz; C Trebst; B G Weinshenker; B Wildemann
Journal:  J Neuroinflammation       Date:  2018-05-03       Impact factor: 8.322
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.